“…More specifically, the Q-isozymes exhibit lower activity, while the QR heterozygotes and R homozygotes possess higher activity [ 8 , 21 , 30 ] against most of the substrates. Consequently, it has been suggested that the Q/R polymorphism of PON1 affects an individual person’s response to, for instance, several toxic substrates [ 21 , 31 ]. Thus, PON1 polymorphism is of considerable interest due to its possible association with a number of diseases such as cardiovascular disease [ 32 , 33 , 34 , 35 , 36 , 37 ], carotid atherosclerosis [ 38 ], Parkinson [ 39 , 40 ], panic disorder [ 41 ], multiple sclerosis [ 42 ] and Alzheimer’s disease [ 43 ].…”